Kaléo Announces Authorised Generic Evzio At A Fraction Of The Cost

Politicians and the public admonished Kaléo for pricing its opioid overdose revival agent at more than US$4,000 per unit; now the originator says an authorized generic version, costing only US$178, will hit shelves midway through next year.

DollarNotes
Kaleo's pricing strategy for Evzio faced criticism • Source: Shutterstock

Kaléo has announced plans to offer an authorized generic of its Evzio (naloxone hydrochloride) take-home auto-injector at a list price reportedly 96% lower than the brand, following a public backlash fuelled by America’s deepening opioid public health crisis.

At a list price of US$178 for a two-pack carton, the Virginia-based firm’s authorized generic Evzio product will be offered...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Drug Pricing

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.